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Editorial on the Research Topic
Unravelling T. cruzi Biology
Trypanosoma cruzi, a protozoan parasite that causes Chagas disease, affects an estimated 8 million
people, mainly in Latin America, but also in many developed countries where the disease is not
endemic. Options for drug treatment are limited and not fully effective, especially in the chronic
phase of the disease. The genetic complexity of T. cruzi, with a number of gene families with
hundreds of members and genes of unknown function, in addition to the absence of efficient
techniques for genetic manipulation before the CRISPR era, have contributed to the slow progress
in understanding the biology of this parasite. The aim of this Research Topic is to provide an
overview of the current knowledge on diverse aspects of T. cruzi biology.We received contributions
ranging from molecular and cellular approaches to evaluate gene function and analyze parasite
organelles, to studies on parasite-host interactions, signal transduction during infection, alternative
pathways for identification of new drug targets, pathology of Chagas disease in animal model and
T. cruzi biology in the wild environment, as well as in different stages of the parasite’s life cycle.
Several studies in this topic assessed T. cruzi gene functions using the CRISPR/Cas9 system.
Using a CRISPR/Cas9-riboswitch-based method, Lander et al. succeeded in the downregulation at
themRNA level of genes encoding glycoprotein 72 (TcGP72) and vacuolar proton pyrophosphatase
(TcVP1), as proof of concept. They found that TcVP1 is not essential for the viability of
epimastigotes or the infective stages of T. cruzi, although it is important for normal growth
of epimastigotes in rich medium, and for trypomastigote invasion of host cells. Also using
CRISPR/Cas9, Malvezzi et al. generated T. cruzi devoid of TcK1, an ortholog of the protein
kinase named general control non-repressible 2 (GCN2) that phosphorylates the eukaryotic
initiation factor 2 alpha subunit (eIF2α). Under starvation, TcK1 depleted cells showed reduced
accumulation of stress RNA granules, independently of eIF2α phosphorylation. In absence of
TcK1, metacyclogenesis increased, but the trypomastigotes were less infective to mammalian host
cells. Regarding T. cruzi structure, Chasen et al. used a combination of CRISPR/Cas9-mediated
endogenous tagging, fluorescently labeled overexpression constructs and endocytic assays, to
identify the first known cytostome-cytopharynx complex (SPC) targeted protein (CP1), which co-
localizes with endocytosed protein and disassembles in infective forms of T. cruzi. Two additional
proteins that target to SPC (CP2 and CP3) were also identified. In addition, they defined the
location of a region adjacent to the SPC entrance, known as the pre-oral ridge (POR), which
lies between the entrance of the flagellar pocket and the cytostome. CRISPR/Cas9 technology was
also used by Grazielle-Silva et al. to investigate the involvement of DNA mismatch repair (MMR)
component MSH6 in the oxidative stress response in T. cruzi, by generating MSH6 null mutants.
The loss of one or two alleles of T. cruzi msh6 resulted in increased susceptibility to H2O2 exposure,
besides impaired MMR. They confirmed that MSH2 associated with MSH6 is a central component
of the MMR pathway responsible for the recognition and correction of base mismatches that occur
during DNA replication and recombination. In their review on RNA binding proteins (RBPs)
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and gene expression regulation in T. cruzi. Romagnoli et al.
also presented data on downregulation of three RBPs, by
using the CRISPR/Cas9 technique. RBP silencing affected cell
division. References were made to the characterization of
messenger ribonucleoprotein (mRNP) particles, which can be
organized into larger complexes forming stress RNA granules,
depending on RBPs. They suggest that protein composition of
the mRNPs as well as the localization and fate of mRNAs, and
consequently of the genes expressed, depend on RBPs, which
allow the coordinated expression of mRNAs encoding proteins
that are related in function, resulting in the formation of post-
transcriptional operons. All of these studies highlight the impact
that CRISPR/Cas9 technology has had on T. cruzi research.
Ramirez discussed the co-evolution of telomeres,
subtelomeres, and the trans- sialidase type II (TSII) family,
and the role that these regions may have played in shaping T.
cruzi’s genome. It is suggested that these regions, together with
retrotransposon elements, promote the generation of genetic
variability, and that members of the TS II family positioned
at the subtelomeres co-evolved to be part of the transition to
the telomeric repeat. This review also proposed that double
strand breaks introduced in the subtelomeres by retrotransposon
nucleases are repaired by homologous recombination, and
when the repair includes non-homologous chromatids there is a
possibility to generate gene variants.
To survive the inimical conditions T. cruzi encounters
in the insect vector and the mammalian host, the parasite
has to adapt to distinct microenvironments, where nutrient
availability, osmolarity, ionic concentrations, and pH vary
significantly. Mesías et al. reviewed the current knowledge of
the oxidant environment experienced by T. cruzi in the insect
and mammalian hosts, and the molecular strategies exploited
by the parasite to deal with oxidative stress. T. cruzi utilizes
a network of antioxidant enzymes to control the cytotoxic
effects of reactive oxygen species (ROS) and reactive nitrogen
species (RNS) to which they are exposed in the triatomine and
the mammalian hosts. In their review, Melo et al. discussed
how environmental factors, such as temperature, availability
of nutrients and consequent oxidative and osmotic stresses
may alter T. cruzi development in the triatomine insect.
Replication of epimastigotes and differentiation into metacyclic
trypomastigotes are affected by these factors. Another study
in this Research Topic investigated T. cruzi adaptation to
different environments. Barrera et al. aimed at characterizing
an ion channel that plays a critical role in parasite survival.
They identified and characterized the expression pattern and
function of a novel calcium-activated potassium channel
(TcCAKC), which resides in the plasma membrane of all
three life stages of T. cruzi. They generated TcCAKC null
parasites, which showed impaired growth, decreased production
of trypomastigotes and slower intracellular replication.
Epimastigotes lacking the channel had significantly lower
cytosolic calcium, hyperpolarization, changes in intracellular
pH, and increased proton extrusion rate.
Trypanosoma. cruzi infection may induce the inflammatory
process that ultimately lead to myocardiopathy. Extracellular
vesicles (EVs) shed by trypomastigote forms of T. cruzi could
be involved in promoting inflammation. Cronemberger-Andrade
et al. have found that T. cruzi-infected macrophages shed EVs
that interact with Toll-like-receptor 2 (TLR2) and stimulate the
translocation of NF-κB, inducing expression of proinflammatory
cytokines (TNF-α, IL-6, and IL-1β), and STAT-1 and STAT-3
signaling pathways. In addition, EVs from parasites or from
T. cruzi-infected macrophages enhanced host cell invasion.
Nisimura et al. re-analyzed previous microarray dataset from
four different T. cruzi strains, in order to better understand
the transcriptomic impact that each strain has on JAK-STAT
signaling and cell cycle pathways. They reported that T. cruzi
strains differentially alter the expression of JAK-STAT signaling,
whose activation may lead to muscle cell hypertrophy, and
distinctly modulate cell cycle pathways.
Identification of targets for new drugs to treat Chagas disease
is an important issue. Moreover, the ability of T. cruzi to establish
dormancy associated with resistance to drug treatment has been
recently reported. Using different T. cruzi DTUs during their
replicative epimastigote and amastigote stages, Resende et al.
investigated the influence of recombinational processes to induce
dormancy in T. cruzi. For both epimastigote and amastigote
forms, the number of dormant cells was higher in hybrid
than in non-hybrid strains. Treatment of T. cruzi with gamma
radiation, which generates DNA lesions repaired by homologous
recombination, resulted in increased percentage of dormancy.
In parasites harboring single knockout for RAD51, there was a
significant reduction in the number of dormant cells. Altogether,
these data suggest the existence of an adaptive difference among
T. cruzi strains to generate dormant cells, and that homologous
recombination could be important for dormancy in this parasite.
Potential therapeutic targets for treatment of T. cruzi infection
have been identified by exploiting the differences between the
mechanisms involved in intracellular Ca2+ signaling in humans
and trypanosomatids. Benaim et al. reviewed data that support
targeting Ca2+ homeostasis as a strategy against Chagas disease
by giving examples of reported drugs with trypanocidal effects.
In another review, Quiñones et al. discussed the potential of
glycosomal enzymes, which are essential for the trypanosomatid
viability, as drug targets. Biochemical and proteomic analysis
of glycosomes have revealed the integration of glycosomes in
overallT. cruzimetabolism. In these authors’ view, the differences
in human and trypanosomatid proteins make a variety of
glycosomal enzymes promising drug targets. It is also referred
that selective, potent inhibitors of some glycosomal proteins have
been demonstrated to interfere with metabolic processes.
Carvalho et al. conducted a robust echocardiographic
evaluation of left ventricular (LV) function in dogs chronically
infected with T. cruzi. Parameters analyzed included end-systolic
volume (ESV), end-diastolic volume (EDV), ejection fraction
(EF), and fractional shortening (FS). A significant LVEF and
FS reduction was observed in infected animals compared to
controls. The authors concluded that the canine model of
chronic chagasic cardiomyopathy (CCC) mimics human disease,
reproducing the percentage of individuals that develop heart
failure during the chronic infection.
In an integrative review, Martinez et al. discussed the current
state of diagnosis and prognosis of Chagas disease, the treatment
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for the disease, approaches to improve treatment, as well as
host factors and parasite susceptibility and resistance to drug.
Prediction of disease outcome and determining whether and
when treatment of infection may be necessary, still remains as
a prospect to be fulfilled.
T. cruzi is primarily a parasite of wild mammals. Jansen
et al. reviewed T. cruzi biology in the natural environment. They
discussed among other topics: T. cruzi genotypes and ecology,
transmission in nature, T. cruzi biology in opossums, mixed
infections and the recent outbreaks of acute Chagas disease by
oral infection.
Overall, this Research Topic brings together an important
collection of articles focused on fundamental aspects of T.
cruzi biology, using state-of-the-art technology to elucidate
the function of proteins and the metabolic pathways to
which they belong; as well as reviewing the current literature
involving the main features of the parasite that causes
Chagas disease.
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